Literature DB >> 2106006

Serological evidence that dry heating of clotting factor concentrates prevents transmission of non-A, non-B hepatitis.

S J Skidmore1, K J Pasi, S J Mawson, M D Williams, F G Hill.   

Abstract

A new test for antibodies specific for an agent causing non-A, non-B hepatitis (NANBH) was used to screen 45 children with coagulation disorders who received factor concentrates. It was found that the test results correlated with clinical evidence of NANBH and that heat treatment of concentrates (80 degrees C for 72 hours) appears to have prevented transmission of NANBH.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2106006     DOI: 10.1002/jmv.1890300111

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  2 in total

1.  Hepatitis C virus and transfusion transmitted liver disease.

Authors:  M Contreras; J A Barbara; M Brennan
Journal:  J Clin Pathol       Date:  1991-02       Impact factor: 3.411

Review 2.  Hepatitis C-Z: recent advances.

Authors:  D Kelly; S Skidmore
Journal:  Arch Dis Child       Date:  2002-05       Impact factor: 3.791

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.